Please wait a minute...


China Biotechnology
China Biotechnology  2016, Vol. 36 Issue (9): 126-133    DOI: 10.13523/j.cb.20160916
The Current Research and Development Status of Cell Drug
WANG Dian-liang1, DU Juan2
1 Tissue Engineering and Regenerative Medicine Laboratory, The General Hospital of The PLA Rocket Force, Beijing 100088, China;
2 Medical Affairs Department, The General Hospital of The PLA Rocket Force, Beijing 100088, China
Download:   PDF(504KB) HTML
Export: BibTeX | EndNote (RIS)      


In recent years, the research of cell drug has been paid more attention at home and abroad. Stem cell drug, in particular, has become a hot research field around the world. The vast majority of stem cell drugs in various countries are still in the research stage, and only a few of stem cell drugs have come into the market. The currently developing stem cell drugs are focused on the treatment of chronic diseases (arthritis, diabetes and cancer, etc.) and heart related diseases (myocardial infarction, heart failure, etc.). Some traditional somatic cell drugs (such as chondrocytes, cardiac muscle cells, islet cells, etc.) and immune cell drugs have already been used in clinic.

Key wordsCell drug      Cell product      Stem cell      Somatic cell      Immune cell      Clinical application     
Received: 04 February 2016      Published: 02 March 2016
ZTFLH:  Q819  
Cite this article:

WANG Dian-liang, DU Juan. The Current Research and Development Status of Cell Drug. China Biotechnology, 2016, 36(9): 126-133.

URL:     OR

[1] Peng Y.The patentability of human embryonic stem cell technology in China. Nat Biotechnol,2016,34(1):37-39.
[2] Plaza Reyes A, Petrus-Reurer S, Antonsson L, et al. Xeno-free and defined human embryonic stem cell-derived retinal pigment epithelial cells functionally integrate in a large-eyed preclinical model.Stem Cell Reports,2016,6(1):9-17.
[3] Sugarman J. Human stem cell ethics:beyond the embryo. Cell Stem Cell, 2008,2(6):529-533.
[4] Tartarini D, Mele E. Adult stem cell therapies for wound healing:biomaterials and computational models.Front Bioeng Biotechnol,2016,3:206.
[5] Clevers H. What is an adult stem cell.Science, 2015,350(6266):1319-1320.
[6] Devitt S M, Carter C M, Dierov R, et al.Successful isolation of viable adipose-derived stem cells from human adipose tissue subject to long-term cryopreservation:positive implications for adult stem cell-based therapeutics in patients of advanced age.Stem Cells Int,2015,2015:146421.
[7] Branch M J, Yu W Y, Sheridan C, et al.Isolation of adult stem cell populations from the human cornea.Methods Mol Biol,2015,1235:165-177.
[8] Park B W.Dental tissues as adult stem cell source. J Korean Assoc Oral Maxillofac Surg,2013,39(2):41-42.
[9] Martinez-Schlurmann N I, Rampa S, Speicher D G, et al.Prevalence, predictors and outcomes of cardiopulmonary resuscitation in hospitalized adult stem cell transplant recipients in the United States:not just opening the black box but exploring an opportunity to optimize.Bone Marrow Transplant,2015,50(12):1578-1581.
[10] Fukada S, Ma Y, Uezumi A. Adult stem cell and mesenchymal progenitor theories of aging.Front Cell Dev Biol,2014,2:10.
[11] Trainor N, Pietak A, Smith T. Rethinking clinical delivery of adult stem cell therapies.Nat Biotechnol,2014,32(8):729-735.
[12] Erbey F, Atay D, Akcay A, et al.Mesenchymal stem cell treatment for steroid refractory graft-versus-host disease in children:A Pilot and First Study from Turkey.Stem Cells Int,2016,2016:1641402.
[13] Aras Y, Sabanci P A, Kabatas S, et al. The effects of adipose tissue-derived mesenchymal stem cell transplantation during the acute and subacute phases following spinal cord injury.Turk Neurosurg,2016,26(1):127-139.
[14] Wang L, Zhang Y, Li H, et al.Clinical observation of employment of umbilical cord derived mesenchymal stem cell for juvenile idiopathic arthritis therapy.Stem Cells Int,2016,2016:9165267.
[15] Pati S, Muthuraju S, Hadi R A, et al.Neurogenic plasticity of mesenchymal stem cell, an alluring cellular replacement for traumatic brain injury.Curr Stem Cell Res Ther,2016,11(2):149-157.
[16] Rainone V, Martelli C, Ottobrini L, et al. Immunological characterization of whole tumour lysate-loaded dendritic cells for cancer Immunotherapy.PLoS One,2016,11(1):e0146622.
[17] Wei F Q, Sun W, Wong T S, et al. Eliciting cytotoxic T lymphocytes against human laryngeal cancer-derived antigens:evaluation of dendritic cells pulsed with a heat-treated tumor lysate and other antigen-loading strategies for dendritic-cell-based vaccination.J Exp Clin Cancer Res, 2016,35(1):18.
[18] Wei X C, Yang D D, Han X R, et al. Bioactivity of umbilical cord blood dendritic cells and anti-leukemia effect.Int J Clin Exp Med, 2015,8(10):19725-19730.
[19] Chen Y, Lin J, Guo Z Q, et al.MHC I-related chain a expression in gastric carcinoma and the efficacy of immunotherapy with cytokine-induced killer cells. Am J Cancer Res,2015,5(10):3221-3230.
[20] Wang Y, Xu Z, Zhou F, et al. The combination of dendritic cells-cytotoxic T lymphocytes/cytokine-induced killer (DC-CTL/CIK) therapy exerts immune and clinical responses in patients with malignant tumors. Exp Hematol Oncol,2015,4:32.
[21] Li W, Wang Y, Kellner D B, et al. Efficacy of cytokine-induced killer cells in the treatment of elderly patients with metastatic pancreatic adenocarcinoma.Cent Eur J Immunol,2015,40(2):188-193.

[1] XU Zhu, ZHUGE Qi-chuan, HUANG Li-jie. Advances in Stem Cell 3D Scaffolds[J]. China Biotechnology, 2017, 37(9): 112-117.
[2] YUAN Ya-hong, ZHAO Shan-shan, WANG Xiao-li, TENG Zhi-ping, LI Dong-sheng, ZENG Yi. HIV-1 Tat Protein Inhibits the Hematopoiesis Support Function of Bone Marrow Mesenchymal Stem Cells[J]. China Biotechnology, 2017, 37(6): 1-8.
[3] JIANG Chun-lian, WANG Yan-lu, LUO Yu-ping. Development of Neurogenesis in the Adult Mammalian[J]. China Biotechnology, 2017, 37(5): 107-112.
[4] LIN Ji-zhi, WANG Qiang, DIAO Yong. Mesenchymal Stem Cells Secretome: A Novel Alternate Therapy for Wound Healing[J]. China Biotechnology, 2017, 37(4): 104-109.
[5] SUN Yuan-yuan, LI Wei, YE Shou-dong, LIU Da-hai. Gadd45g Induces Mesendodermal Differentiation in Mouse Embryonic Stem Cells[J]. China Biotechnology, 2017, 37(4): 9-17.
[6] CAO Jun-jie, LI Ai-fang, WEI Ya-lin, LIAN Jing, TANG Min. Role of Notch Signaling Pathway in Bone Morphogenetic Protein 4-induced Osteogenic Differentiation of Marrow-derived Mesenchymal Stem Cells and Its Mechanism[J]. China Biotechnology, 2017, 37(4): 48-55.
[7] CHEN Gang, WU Jun, ZHU He, YU Tian-fei. Progress of Stem Cell Therapy in Spinal Cord Injury[J]. China Biotechnology, 2017, 37(2): 88-92.
[8] WANG Dian-liang. The Problems, Solutions and Prospects of Cell Drug[J]. China Biotechnology, 2017, 37(2): 127-132.
[9] ZHAO Zheng-de, CHEN Zhen-yin, ZHANG Hui-nan, GONG Jian-ping, XU Shao-dan, LUO Zhong-li. Effects of Self-assembling Peptide Hydrogel Scaffolds for Three-dimensional Culture on Biological Behavior and Capability of Myocardium Differentiation in Bone Marrow Mesenchymal Stem Cells[J]. China Biotechnology, 2017, 37(11): 45-51.
[10] MAO Kai-yun, FAN Yue-lei, WANG Yue, LU Jiao, CHEN Da-ming. Development Status and Trend Analysis of Mesenchymal Stem Cells Therapeutic Products[J]. China Biotechnology, 2017, 37(10): 126-135.
[11] LIU Yi-jie, XUE Yong-chang. The Research Progress of Flavonoids in Plants[J]. China Biotechnology, 2016, 36(9): 81-86.
[12] CHEN Bing, KONG Ling-jiao, LEI Jin-xia, SHEN Lu, ZHANG Cai, WANG Jin-hua. BMP9 Induces Osteogenic/odontogenic Differentiation of ISCAP through the Smad Pathway[J]. China Biotechnology, 2016, 36(8): 16-22.
[13] WANG Dian-liang. The Preparation Technology of Cell Drug[J]. China Biotechnology, 2016, 36(7): 127-133.
[14] XIA Meng, TIAN Xiao-hong, BAI Shu-ling, HOU Wei-jian. Optimization of Induced Pluripotent Stem Cell Technology and Its Application Prospect[J]. China Biotechnology, 2016, 36(6): 87-91.
[15] ZHANG Qing-fang, LIU Ru-ming, XIAO Jian-hui. Application of Hyaluronic Acid on the Cartilage Differentiation of Mesenchymal Stem Cells[J]. China Biotechnology, 2016, 36(6): 92-99.